“Yiqi Huayu, Wenyang Lishui” Prescription (YHWLP) Improves the Symptoms of Chronic Obstructive Pulmonary Disease-Induced Chronic Pulmonary Heart Disease by Inhibiting the RhoA/ROCK Signaling Pathway

Table 3

Comparison of PT, aPTT, Fbg, and D-dimer (after treatment vs. baseline) in each group.

Group		PT (s)	aPTT (s)	Fbg (g/L)	D-D (mg/L)
YHWLP (n = 40)	Baseline	14.64 ± 2.36	42.21 ± 3.77	5.59 ± 0.74	5.01 ± 1.24
	After	11.69 ± 1.79	37.96 ± 2.99	2.93 ± 1.33	1.92 ± 0.98
Control (n = 40)	Baseline	13.73 ± 1.55	40.79 ± 3.11	5.38 ± 0.69	5.42 ± 0.79
	After	12.28 ± 1.33	38.67 ± 3.29	4.10 ± 0.87	3.89 ± 1.43

Notes: PT, prothrombin time; aPTT, activated partial thromboplastin time; Fbg, fibrinogen; D-D, D-dimer. Values are mean ± standard deviation. , .